| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |